References

Abbott, B.D., and L.S. Birnbaum. 1990. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106(3):418-432.

Abbott, B.D., J.J. Diliberto, and L.S. Birnbaum. 1989. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100(1):119-131.

Abbott, B.D., M.W. Harris, and L.S. Birnbaum. 1992. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45(1):35-53.

Abbott, B.D., G.H. Perdew, and L.S. Birnbaum. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126(1):16-25.

Abbott, B.D., M.R. Probst, G.H. Perdew, and A.R. Buckalew. 1998. AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58(2):30-43.

Abbott, B.D., G.A. Held, C.R. Wood, A.R. Buckalew, J.G. Brown, and J. Schmid. 1999a. AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol. Sci. 47(1):62-75.

Abbott, B.D., J.E. Schmid, J.G. Brown, C.R. Wood, R.D. White, A.R. Buckalew, and G.A Held. 1999b. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci. 47(1):76-85.

Abel, E.A. 1995. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol. Teratol. 17(4):445-462.

Adams, M.D., et al. 2000. The genome sequence of Drosophila melanogaster. Science 287(5461):2185-2196.

Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment References Abbott, B.D., and L.S. Birnbaum. 1990. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol. Appl. Pharmacol. 106(3):418-432. Abbott, B.D., J.J. Diliberto, and L.S. Birnbaum. 1989. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters embryonic palatal medial epithelial cell differentiation in vitro. Toxicol. Appl. Pharmacol. 100(1):119-131. Abbott, B.D., M.W. Harris, and L.S. Birnbaum. 1992. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology 45(1):35-53. Abbott, B.D., G.H. Perdew, and L.S. Birnbaum. 1994. Ah receptor in embryonic mouse palate and effects of TCDD on receptor expression. Toxicol. Appl. Pharmacol. 126(1):16-25. Abbott, B.D., M.R. Probst, G.H. Perdew, and A.R. Buckalew. 1998. AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF alpha, TGF beta 1, TGF beta 2, and TGF beta 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Teratology 58(2):30-43. Abbott, B.D., G.A. Held, C.R. Wood, A.R. Buckalew, J.G. Brown, and J. Schmid. 1999a. AhR, ARNT, and CYP1A1 mRNA quantitation in cultured human embryonic palates exposed to TCDD and comparison with mouse palate in vivo and in culture. Toxicol. Sci. 47(1):62-75. Abbott, B.D., J.E. Schmid, J.G. Brown, C.R. Wood, R.D. White, A.R. Buckalew, and G.A Held. 1999b. RT-PCR quantification of AHR, ARNT, GR, and CYP1A1 mRNA in craniofacial tissues of embryonic mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Sci. 47(1):76-85. Abel, E.A. 1995. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol. Teratol. 17(4):445-462. Adams, M.D., et al. 2000. The genome sequence of Drosophila melanogaster. Science 287(5461):2185-2196. Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994a. Dose-response assessment for developmental toxicity. III. Statistical models. Fundam. Appl. Toxicol. 23(4):496-509.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Allen, B.C., R.J. Kavlock, C.A. Kimmel, and E.M. Faustman. 1994b. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487-495. Allen, B.C., P.L. Strong, C.J. Price, S.A. Hubbard, and G.P. Daston. 1996. Benchmark dose analysis of developmental toxicity in rats exposed to boric acid. Fundam. Appl. Toxicol. 32(2):194-204. Alles, A.J., and K.K. Sulik. 1989. Retinoic-acid-induced limb-reduction defects: Perturbation of zones of programmed cell death as a pathogenetic mechanism. Teratology 40(2):163-171. Alon, U., N. Barkai, D.A. Notterman, K. Gish, S. Ybarra, D. Mack, and A.J. Levine. 1999. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. U.S.A. 96(12):6745-6750. Alonso-Aperte, E., N. Ubeda, M. Achon, J. Perez-Miguelsanz, and G. Varela-Moreiras. 1999. Impaired methionine synthesis and hypomethylation in rats exposed to valproate during gestation. Neurology 52(4):750-756. Amsterdam, A., S. Burgess, G. Golling, W. Chen, Z. Sun, K. Townsend, S. Farrington, M. Haldi, and N. Hopkins. 1999. A large-scale insertional mutagenesis screen in zebrafish. Genes. Dev. 13(20):2713-2724. Anderson, N.G., and L. Anderson. 1982. The Human Protein Index. Clin. Chem. 28(4 Pt. 2):739-748. Anderson, N.L., and N.G. Anderson. 1998. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 19(11):1853-1861. Andrews, J.E., M. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1995. Validation of an in vitro teratology system using chiral substances: Stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos. Toxicol. Appl. Pharmacol. 132(2):310-316. Andrews, J.E., M.T. Ebron-McCoy, U. Bojic, H. Nau, and R.J. Kavlock. 1997. Stereoselective dysmorphogenicity of the enantiomers of the valproic acid analogue 2-N-propyl-4-pentynoic acid (4-yn-VPA): cross-species evaluation in whole embryo culture. Teratology 55(5):314-318. Arman, E., R. Haffner-Krausz, Y. Chen, J.K. Heath, and P. Lonai. 1998. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc. Natl. Acad. Sci. U.S.A 95(9):5082-5087. Artavanis-Tsakonas, S., M.D. Rand, and R.J. Lake. 1999. Notch signaling: Cell fate control and signal integration in development. Science 284(5415):770-776. Baggs, R.B., R.K. Miller, and C.L. Odoroff. 1991. Carcinogenicity of diethylstilbestrol in the Wistar rat: effect of postnatal oral contraceptive steroids. Cancer Res. 51(12):3311-3315. Bailey, A., A. Le Couteur, I. Gottesman, P. Bolton, E. Simonoff, E. Yuzda, and M. Rutter. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol. Med. 25(1):63-77. Baker, N.E., and S.Y. Yu. 1997. Proneural function of neurogenic genes in the developing Drosophila eye. Curr. Biol. 7(2):122-132. Baker, K., K.S. Warren, G. Yellen, and M.C. Fishman. 1997. Defective “pacemaker” current (Ih) in a zebrafish mutant with a slow heart rate. Proc. Natl. Acad. Sci. U.S.A. 94(9):4554-4559. Baldwin, H.S., and M. Artman. 1998. Recent advances in cardiovascular development: Promise for the future. Cardiovasc. Res. 40(3):456-468. Bantle, J.A., R.A. Finch, D.T. Burton, D.J. Fort, D.A. Dawson, G. Linder, J.R. Rayburn, M. Hull, M. Kumsher-King, A.M. Gaudet-Hull, and S.D. Turley. 1996. FETAX interlaboratory validation study: Phase III—Part 1 testing. J. Appl. Toxicol. 16(6):517-528. Barber, C.V., and A.G. Fantel. 1993. The role of oxygenation in embryotoxic mechanisms of three bioreducible agents. Teratology 47(3):209-223. Bargmann, C.I. 1998. Neurobiology of the Caenorhabditis elegans genome. Science 282(5396):2028-2033. Bargmann, C.I., and I. Mori. 1997. Chemotaxis and termotaxis. Pp. 717-737 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Barker, D.J. 1999. Fetal origins of cardiovascular disease. Ann. Med. 31(Suppl. 1):3-6. Barr, M., Jr. 1997. Growth as a manifestation of teratogenesis: Lessons from human fetal pathology. Reprod. Toxicol. 11(4):583-587. Barth, L.G. 1939. The chemical nature of the amphibian organizer: III. Stimulation of the presumptive epidermis of ambystoma by means of cell extracts and chemical substances. Physiol. Zool. 12:22-29. Battula, N., J. Sagara, and H.V. Gelboin. 1987. Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P-450 in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 84(12):4073-4077. Bayer, S.A., J. Altman, R.J. Russo, and X. Zhang. 1993. Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14(1):83-144. Beachy, P.A., M.K. Cooper, K.E. Young, D.P. von Kessler, W.J. Park, T.M. Hall, D.J. Leahy, and J.A. Porter. 1997. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling. Cold Spring Harb. Symp. Quant. Biol. 62:191-204. Becerra, J.E., M.J. Khoury, J.F. Cordero, and J.D. Erickson. 1990. Diabetes mellitus during pregnancy and risks for specific birth defects: A population-based case-control study. Pediatrics 85(1):1-9. Bechter, R., G.D. Terlouw, M. Tsuchiya, T. Tsuchiya, and A. Kistler. 1992. Teratogenicity of arotinoids (retinoids) in the rat whole embryo culture. Arch. Toxicol. 66(3):193-197. Behringer, R.R., D.A. Crotty, V.M. Tennyson, R.L. Brinster, R.D. Palmiter, and D.J. Wolgemuth. 1993. Sequences 5' of the homeobox of the Hox-1.4 gene direct tissue-specific expression of lacZ during mouse development. Development 117(3):823-833. Bellen, H.J. 1998. The fruit fly: A model organism to study the genetics of alcohol abuse and addiction? Cell 93(6):909-912. Bellinger, D. 1994. Teratogen update: Lead. Teratology 50:367-373. Best, J.B., and M. Morita. 1991. Toxicology of planarians. Hydrobiologia 227:375-383. Binns, W., L. James, J.L. Shupe, and W.T. Huffman. 1963. A congenital cyclopian-type malformation in lambs induced by maternal ingestion of a range plant, Veratrum californicum. Am. J. Vet. Res. 24(103):1164-1175. Blackwood, E.M., and J.T. Kadonaga. 1998. Going the distance: A current view of enhancer action. Science 281(5373):61-63. Bladt, F., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376(6543):768-771. Bodey, B., B. Bodey, Jr., S.E. Siegel, and H.E. Kaiser. 1999. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment. In Vivo 13(3):267-294. Bojic, U., M.M. Elmazar, R.S. Hauck, and H. Nau. 1996. Further branching of valproate-related carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Chem. Res. Toxicol. 9(5):866-870. Bojic, U., K. Ehlers, U. Ellerbeck, C.L. Bacon, E. O’Driscoll, C. O’Connell, V. Berezin, A. Kawa, E. Lepekhin, E. Bock, C.M. Regan, and H. Nau. 1998. Studies on the teratogen pharmacophore of valproic acid analogues: Evidence of interactions at a hydrophobic centre. Eur. J. Pharmacol. 354(2-3):289-299. Bostrom, H., K. Willetts, M. Pekny, P. Leveen, P. Lindahl, H. Hedstrand, M. Pekna, M. Hellstrom, S. Gebre-Medhin, M. Schalling, M. Nilsson, S. Kurland, J. Tornell, J.K. Heath, and C. Betsholtz. 1996. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85(6):863-873. Bournias-Vardiabasis, N. 1990. Drosophila-melanogaster embryo cultures: An in vitro teratogen assay. ATLA, Altern. Lab. Anim. 18:291-300.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Brambilla, R., N. Gnesutta, L. Minichiello, G. White, A.J. Roylance, C.E. Herron, M. Ramsey, D.P. Wolfer, V. Cestari, C. Rossi-Arnaud, S.G. Grant, P.F. Chapman, H.P. Lipp, E. Sturani, and R. Klein. 1997. A role for the Ras signalling pathway in synaptic transmission and long- term memory. Nature 390(6657):281-286. Brand-Saberi, B., and B. Christ. 1999. Genetic and epigenetic control of muscle development in vertebrates. Cell Tissue Res. 296(1):199-212. Brandsma, A.E., D. Tibboel, I.M. Vulto, J.J. de Vijlder, A.A. Ten Have-Opbroek, and W.M. Wiersinga. 1994. Inhibition of T3-receptor binding by Nitrofen. Biochim. Biophys. Acta 1201(2):266-270. Braun, A.G., C.A. Buckner, D.J. Emerson, and B.B. Nichinson. 1982. Quantitative correspondence between the in vivo and in vitro activity of teratogenic agents. Proc. Natl. Acad. Sci. U.S.A. 79(6):2056-2060. Brenner, S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71-94. Brewster, R., and N. Dahmane. 1999. Getting ahead of the organizer: Anterior- posterior patterning of the forebrain. Bioessays 21(8):631-636. Bridgeman, A.M., D. Buck, J. Burgess, W.D. Burrill, K.P. O’Brien, et al. 1999. The DNA sequence of human chromosome 22. Nature 402(6761):489-495. Briggs, R., and T.J. King. 1952. Transplantation of living nuclei from blastula cells into enucleated frog eggs. Proc. Natl. Acad. Sci. U.S.A. 38:455-462. Brockerhoff, S.E., J.B. Hurley, U. Janssen-Bienhold, S.C. Neuhauss, W. Driever, and J.E. Dowling. 1995. A behavioral screen for isolating zebrafish mutants with visual system defects. Proc. Natl. Acad. Sci. U.S.A. 92(23):10545-10549. Brody, L.C., and B.B. Biesecker. 1998. Breast cancer susceptibility genes. BRCA1 and BRCA2. Medicine (Baltimore) 77(3):208-226. Brown, D.L., K.R. Reuhl, S. Bormann, and J.E. Little. 1988. Effects of methyl mercury on the microtubule system of mouse lymphocytes. Toxicol. Appl. Pharmacol. 94(1):66-75. Brown, J.R., H. Ye, R.T. Bronson, P. Dikkes, and M.E. Greenberg. 1996. A defect in nurturing in mice lacking the immediate early gene fosB. Cell 86(2):297-309. Brown, N.A. 1987. Teratogenicity testing in vitro: Status of validation studies. [Review]. Arch. Toxicol. (Suppl.)11:105-114. Brown, N.A., and S.J. Freeman. 1984. Alternative tests for teratogenicity. ATLA, Altern. Lab. Anim. 12(1):7-23. Brown, N.A., M.E. Coakley, and D.O. Clarke. 1987. Pp. 17-31 in Approaches to Elucidate Mechanisms in Teratogenesis, F. Welsch, ed. Washington, DC: Hemisphere Pub. Brown, N.A., J. Kao, and S. Fabro. 1980. Teratogenic potential of valproic acid. [letter]. Lancet 1(8169):660-661. Brown, N.A., H. Spielmann, R. Bechter, O.P. Flint, S.J. Freeman, R.J. Jelinek, E. Koch, H. Nau, D.R. Newall, A.K. Palmer, J.Y. Renault, M.F. Repetto, R. Vogel, and R. Wiger. 1995. Screening chemicals for reproductive toxicity: The current alternatives: The report and recommendations of an ECVAM/ETS workshop (ECVAM Workshop 12). ATLA, Altern. Lab. Anim. 23(6):868-882. Brown, P.O., and D. Botstein. 1999. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21(1 Suppl.):33-37. Brunet, L.J., J.A. McMahon, A.P. McMahon, and R.M. Harland. 1998. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280(5368):1455-1457. Bryson, S.E., and I.M. Smith. 1998. Epidemiology of autism: Prevalence, associated characteristics and implications for research and service delivery. MRDD Res. Rev. 4:97-103. Bryson, S.E., B.S. Clark, and I.M. Smith. 1988. First report of a Canadian epidemiological study of autistic syndromes. J. Child Psychol. Psychiatry 29(4):433-445. Buehler, B.A. 1984. Epoxide hydrolase activity and the fetal hydantoin syndrome. Proc. Greenwood Genet. Ctr. 3:109-110.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Buehler, B.A., D. Delimont, M. van Waes, and R.H. Finnell. 1990. Prenatal prediction of risk of the fetal hydantoin syndrome. N. Engl. J. Med. 322(22):1567-1572. Bui, L.M., M.W. Taubeneck, J.F. Commisso, J.Y. Uriu-Hare, W.D. Faber, and C.L. Keen. 1998. Altered zinc metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid, 2-ethylhexanol and valproic acid. Toxicology 126(1):9-21. Burbacher, T.M., P.M. Rodier, and B. Weiss. 1990. Methylmercury developmental neurotoxicity: A comparison of effects in humans and animals. Neurotoxicol. Teratol. 12(3):191-202. Burke, A.C. 2000. Hox genes and the global patterning of the somitic mesoderm. Curr. Top. Dev. Biol. 47:155-181. Cahill, G.M., M.W. Hurd, and M.M. Batchelor. 1998. Circadian rhythmicity in the locomotor activity of larval zebrafish. Neuroreport 9(15):3445-3449. California Environmental Protection Agency. 1991. Draft Guidelines for Hazard Identification and Dose-Response Assessment of Agents Causing Developmental and/or Reproductive Toxicity. California Dept. of Health Services, Health Hazard Assessment Division. Reproductive and Cancer Hazard Assessment Section. April, 3. Carney, E.W., A.B. Liberacki, M.J. Bartels, and W.J. Breslin. 1996. Identification of proximate toxicant for ethylene glycol developmental toxicity using rat whole embryo culture. Teratology 53(1):38-46. Carpenter, E.M, J.M. Goddard, O. Chisaka, N.R. Manley, and M.R. Capecchi. 1993. Loss of HoxA1 (Hox-1.6) function results in the reorganization of the murine hindbrain. Development 118(4):1063-1075. Cash, D.E., C.B. Bock, K. Schughart, E. Linney, and T.M. Underhill. 1997. Retinoic acid receptor alpha function in vertebrate limb skeletogenesis: A modulator of chondrogenesis. J. Cell Biol. 136(2):445-457. CDC (Centers for Disease Control). 1987. Table V. Estimated years of potential life lost before age 65 and cause-specific mortality, by cause of death-United States, 1985. MMWR 36(20):313. CDC (Centers for Disease Control). 1995. Economic costs of birth defects and cerebral palsy-United States, 1992. MMWR 44:694-699. C. elegans Sequencing Consortium. 1998. Genome sequence of the nematode C. elegans: A platform for investigating biology. Science 282(5396):2012-2018. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: Coexpression of beta-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell Biol. 5(12):3403-3409. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10(9):940-954. Chan, A.W., T. Dominko, C.M. Luetjens, E. Neuber, C. Martinovich, L. Hewitson, C.R. Simerly, and G.P. Schatten. 2000. Clonal propagation of primate offspring by embryo splitting. Science 287(5451):317-319. Chang, C., D.R. Smith, V.S. Prasad, C.L. Sidman, D.W. Nebert, and A. Puga. 1993. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 3(6):312-321. Chanut, F., and U. Heberlein. 1997. Role of decapentaplegic in initiation and progression of the morphogenetic furrow in the developing Drosophila retina. Development 124(2):559-567. Chappell, P.E, J.P. Lydon, O.M. Conneely, B.W. O’Malley, and J.E. Levine. 1997. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology 138(10):4147-4152. Chazaud, C., P. Chambon, and P. Dolle. 1999. Retinoic acid is required in the mouse embryo for left-right asymmetry determination and heart morphogenesis. Development 126(12):2589-2596. Chen, J., A. Nachabah, C. Scherer, P. Ganju, A. Reith, R. Bronson, and H.E. Ruley. 1996. Germ-line inactivation of the murine Eck receptor tyrosine kinase by gene trap retroviral insertion. Oncogene 12(5):979-988.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Chervitz, S.A., L. Aravind, G. Sherlock, C.A. Ball, E.V. Koonin, S.S. Dwight, M.A. Harris, K. Dolinski, S. Mohr, T. Smith, S. Weng, J.M. Cherry, and D. Botstein. 1998. Comparison of the complete protein sets of worm and yeast: Orthology and divergence. Science 282(5396):2022-2028. Chiang, C., Y. Litingtung, E. Lee, K.E. Young, J.L.Corden, H. Westphal, and P.A. Beachy. 1996. Cyclopia and defective axial patterning in mice lacking sonic hedgehog gene function. Nature 383:407-413. Chisaka, O., T.S. Musci, and M.R. Capecchi. 1992. Developmental defects of the ear, cranial nerves and hindbrain resulting from targeted disruption of the mouse homeobox gene Hox-1.6. Nature 355(6360):516-520. Chou, T.B., and N. Perrimon. 1996. The autosomal FLP-DFS technique for generating germline mosaics in Drosophila melanogaster. Genetics 144:1673-1679. Christianson, A.L., N. Chesler, and J.G. Kromberg. 1994. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev. Med. Child Neurol. 36(4):361-369. Chu, S., J. DeRisi, M. Eisen, J. Mulholland, D. Botstein, P.O. Brown, and I. Herskowitz. 1998. The transcriptional program of sporulation in budding yeast. Science 282(5389):699-705. Clark, R.L., R.T. Robertson, D.H. Minsker, S.M. Cohen, D.J. Tocco, H.L. Allen, M.L. James, and D.L. Bokelman. 1984. Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits. Teratology 30(3):319-332. Clarke, D.O., J.M. Duignan, and F. Welsch. 1992. 2-Methoxyacetic acid dosimetry-teratogenicity relationships in CD-1 mice exposed to 2-methoxyethanol. Toxicol. Appl. Pharmacol. 114(1):77-87. Clarke, D.O., B.A. Elswick, F. Welsch, and R.B. Conolly. 1993. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: A physiological based mathematical model. Toxicol. Appl. Pharmacol. 121:239-252. Clarkson, T.W. 1987. The role of biomarkers in reproductive and developmental toxicology. Environ. Health Perspect. 74:103-107. Clarkson, T.W. 1993. Mercury: Major issues in environmental health. Environ. Health Perspect. 100:31-38. Coberly, S., E. Lammer, and M. Alashari. 1996. Retinoic acid embryopathy: Case report and review of literature. Pediatr. Pathol. Lab. Med. 16(5):823-836. Collins, F.S., A. Patrinos, E. Jordan, A. Chakravarti, R. Gesteland, and L. Walters. 1998. New goals for the U.S. Human Genome Project: 1998-2003. Science 282(5389):682-689. Collins, M.D., and G.E. Mao. 1999. Teratology of retinoids. Annu. Rev. Pharmacol. Toxicol. 39:399-430. Collins, T.F., R.L. Sprando, D.L. Hansen, M.E. Shackelford, and J.J. Welsh. 1998. Testing guidelines for evaluation of reproductive and developmental toxicity of food additives in females. Int. J. Toxicol. 17(3):299-325. Colussi, P.A., and S. Kumar. 1999. Targeted disruption of caspase genes in mice: What they tell us about the functions of individual caspases in apoptosis. Immunol. Cell Biol. 77(1):58-63. Colvin, J.S., B.A. Bohne, G.W. Harding, D.G. McEwen, and D.M. Ornitz. 1996. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat. Genet. 12(4):390-397. Conlon, R.A., and J. Rossant. 1992. Exogenous retinoic acid rapidly induces anterior ectopic expression of murine Hox-2 genes in vivo. Development 116(2):357-368. Conlon, R.A., A.G. Reaume, and J. Rossant. 1995. Notch1 is required for the coordinate segmentation of somites. Development 121(5):1533-1545. Cooper, M.K., J.A. Porter, K.E. Young, and P.A. Beachy. 1998. Teratogen-mediated inhibition of target tissue response to Shh signaling. Science 280(5369):1603-1607.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Couture, L.A., B.D. Abbott, and L.S. Birnbaum. 1990. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: Recent advances toward understanding the mechanism. Teratology 42(6):619-627. Crabb, D.W. 1990. Biological markers for increased risk of alcoholism and for quantitation of alcohol consumption. J. Clin. Invest. 85(2):311-315. Crespi, C.L., and V.P. Miller. 1999. The use of heterologously expressed drug metabolizing enzymes—state of the art and prospects for the future. Pharmacol. Ther. 84(2):121-131. Cresteil, T. 1998. Onset of xenobiotic metabolism in children: Toxicological implications. Food Addit. Contam. 15(Suppl.):45-51. Crowley, C., S.D. Spencer, M.C. Nishimura, K.S. Chen, S. Pitts-Meek, M.P. Armanini, L.H. Ling, S.B. MacMahon, D.L. Shelton, A.D. Levinson, et al. 1994. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76(6):1001-1011. Crump, K.S. 1984. An improved procedure for low-dose carcinogenic risk assessment from animal data. J. Environ. Pathol. Toxicol. Oncol. 5(4-5):339-348. Cunha, G.R., J.G. Forsberg, R. Golden, A. Haney, T. Iguchi, R. Newbold, S. Swan, and W. Welshons. 1999. New approaches for estimating risk from exposure to diethylstilbestrol. Environ. Health Perspect. 107(Suppl. 4):625-630. Cushnir, J.R., S. Naylor, J.H. Lamb, P.B. Farmer, N.A. Brown, and P.E. Mirkes. 1990. Identification of phosphoramide mustard/DNA adducts using tandem mass spectrometry. Rapid. Commun. Mass Spectrom. 4(10):410-414. Dareste, M.C. 1877. La production artificielle des monstruosites. C. Reinwald et Cie, Paris. Dasen, J.S., and M.G. Rosenfeld. 1999. Signaling mechanisms in pituitary morphogenesis and cell fate determination. Curr. Opin. Cell Biol. 11(6):669-677. Daston, G.P. 1996. The theoretical and empirical case for in vitro developmental toxicity screens, and potential applications. Teratology 53(6):339-344. Daston, G.P., and L.D. Lehman-McKeeman. 1996. Constitutive and induced metalothionein expression in development. Pp. 1139-1151 in Toxicology of Metals, L.W. Chang, ed. Boca Raton, FL: CRC Press. Daston, G.P., G.J. Overmann, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers, and C.L. Keen. 1991a. The role of metallothionein induction and altered zinc status in maternally mediated developmental toxicity: Comparison of the effects of urethane and styrene in rats. Toxicol. Appl. Pharmacol. 110(3):450-463. Daston, G.P., J.M. Rogers, D.J. Versteeg, T.D. Sabourin, D. Baines, and S.S. Marsh. 1991b. Interspecies comparisons of A/D ratios: A/D ratios are not constant across species. Fundam. Appl. Toxicol. 17(4):696-722. Daston, G.P., G.J. Overmann, D. Baines, M.W. Taubeneck, L.D. Lehman-McKeeman, J.M. Rogers, and C.L. Keen. 1994. Altered Zn status by alpha-hederin in the pregnant rat and its relationship to adverse developmental outcome. Reprod. Toxicol. 8(1):15-24. Daston, G.P., D. Baines, E. Elmore, M.P. Fitzgerald, and S. Sharma. 1995. Evaluation of chick embryo neural retina cell culture as a screen for developmental toxicants. Fundam. Appl. Toxicol. 26(2):203-210. DeChiara, T.M., A. Efstratiadis, and E.J. Robertson. 1990. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345(6270):78-80. Deng, C., M. Bedford, C. Li, X. Xu, X. Yang, J. Dunmore, and P. Leder. 1997. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev. Biol. 185(1):42-54. DeSesso, J.M. 1979. Cell death and free radicals: A mechanism for hydroxyurea teratogenesis. Med. Hypotheses 5(9):937-951.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment DeSesso, J.M., and G.C. Goeringer. 1990. The nature of the embryo-protective interaction of propyl gallate with hydroxyurea. Reprod. Toxicol. 4(2):145-152. DeSesso, J.M., and G.C. Goeringer. 1991. Amelioration by leucovorin of methotrexate developmental toxicity in rabbits. Teratology 43(3):201-215. DeSesso, J.M., and G.C. Goeringer. 1992. Methotrexate-induced developmental toxicity in rabbits is ameliorated by 1-(p-tosyl)-3,4,4-trimethylimidazolidine, a functional analog for tetrahydrofolate-mediated one-carbon transfer. Teratology 45(3):271-283. DeSesso, J.M., A.R. Scialli, and G.C. Goeringer. 1994. D-mannitol, a specific hydroxyl free radical scavenger, reduces the developmental toxicity of hydroxyurea in rabbits. Teratology 49(4):248-259. Dickson, D. 1999. Gene estimate rises as US and UK discuss freedom of access. Nature 401(6751):311. Downward, J., Y. Yarden, E. Mayes, G. Scrace, N. Totty, P. Stockwell, A. Ullrich, J. Schlessinger, and M.D. Waterfield. 1984. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature 307(5951):521-527. Dubnau, J., and T. Tully. 1998. Gene discovery in Drosophila: New insights for learning and memory. Annu. Rev. Neurosci. 21:407-444. Duboule, D. 1998. Vertebrate hox gene regulation: Clustering and/or colinearity? Curr. Opin. Genet. Dev. 8(5):514-518. Dudley, A.T., and E.J. Robertson. 1997. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dyn. 208(3):349-362. Duester, G. 1991. A hypothetical mechanism for fetal alcohol syndrome involving ethanol inhibition of retinoic acid synthesis at the alcohol dehydrogenase step. Alcohol Clin. Exp. Res. 15(3):568-572. Dunham, I., N. Shimizu, B.A. Roe, S. Chissoe, A.R. Hunt, J.E. Collins, R. Bruskiewich, D.M. Beare, M. Clamp, L.J. Smink, R. Ainscough, J.P. Almeida, A. Babbage, C. Bagguley, J. Bailey, K. Barlow, K.N. Bates, O. Beasley, C.P. Bird, S. Blakey, Dupe, V., N.B. Ghyselinck, V. Thomazy, L. Nagy, P.J.A. Davies, P. Chambon, and M. Mark. 1999. Essential roles of retinoic acid signaling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol. 208(1):30-43. Durbin, J.E., R. Hackenmiller, M.C. Simon, and D.E. Levy. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84(3):443-450. Dwivedi, R.S., and P.M. Iannaccone. 1998. Effects of environmental chemicals on early development. Pp. 11-46 in Reproductive and Developmental Toxicology, K.S. Korach, ed. New York: Marcel Dekker. Eastin, W.C., J.K. Haseman, J.F. Mahler, and J.R. Bucher. 1998. The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens. Toxicol. Pathol. 26(4):461-473. Ebert, J.D., and M. Marois. 1976. Tests of Teratogenicity in Vitro: Proceedings of the International Conference on Tests of Teratogenicity In Vitro, Woods Hole, Mass., 1-4 April, 1975. New York: North-Holland Publishing Co. Eckert, D., and M. Merchlinsky. 1999. Vaccinia virus-bacteriophage T7 expression vector for complementation analysis of late gene processes. J. Gen. Virol. 80(Pt. 6):1463-1469. Edlund, T., and T.M. Jessell. 1999. Progression from extrinsic to intrinsic signaling in cell fate specification: A view from the nervous system. Cell 96(2):211-224. Eisen, M.B., P.T. Spellman, P.O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95(25):14863-14868. Eisenhardt, E.U., and M.H. Bickel. 1994. Kinetics of tissue distribution and elimination of retinoid drugs in the rat. II. Etretinate. Drug Metab. Dispos. 22(1):31-35.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Ellsworth, D.L., D.M. Hallman, and E. Boerwinkle. 1997. Impact of the human genome project on epidemiologic research. Epidemiol. Rev. 19(1):3-13. Elmazar, M.M., U. Reichert, B. Shroot, and H. Nau. 1996. Pattern of retinoid-induced teratogenic effects: Possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma. Teratology 53(3):158-167. Elmazar, M.M., R. Ruhl, U. Reichert, B. Shroot, and H. Nau. 1997. RARalpha-mediated teratogenicity in mice is potentiated by an RXR agonist and reduced by an RAR antagonist: Dissection of retinoid receptor-induced pathways. Toxicol. Appl. Pharmacol. 146(1):21-28. Emmert-Buck, M.R., R.F. Bonner, P.D. Smith, R.F. Chuaqui, Z. Zhuang, S.R. Goldstein, R.A. Weiss, and L.A. Liotta. 1996. Laser capture microdissection. Science 274(5289):998-1001. Ensenbach, U., and R. Nagel. 1995. Toxicity of complex chemical mixtures: Acute and long-term effects on different life stages of zebrafish (Brachydanio rerio). Ecotoxicol. Environ. Saf. 30(2):151-157. Ensenbach, U., and R. Nagel. 1997. Toxicity of binary chemical mixtures: Effects on reproduction of zebrafish. Arch. Environ. Contam. Toxicol. 32(2):204-210. EPA (U.S. Environmental Protection Agency). 1990. Fungicide and Rodenticide Act (FIFRA): Good Laboratory Practice Standards. Final Rule. Fed. Regist. 54(158):34052-34074. EPA (U.S. Environmental Protection Agency). 1991. Guidelines for Developmental Toxicity Risk Assessment; Notice. Part V. Fed. Regist. 56(234):63798-63826. EPA (U.S. Environmental Protection Agency). 1995. Guidance for Risk Characterization. Science Policy Council. ORD. February. [Online]. Available: http://search.epa.gov/ordntrnt/ORD/spc/rcguide.htm EPA (U.S. Environmental Protection Agency). 1996a. Guidelines for Reproductive Toxicity Risk Assessment. Fed. Regist. 61(212):56274-56322. EPA (U.S. Environmental Protection Agency). 1996b. Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. Office of Research and Development. Washington, DC. EPA (U.S. Environmental Protection Agency). 1997. TSCA Test Guidelines, 40 CFR Part 799. Fed. Regist. 62(158):43820-438649. EPA (U.S. Environmental Protection Agency). 1998a. Chemical Hazard Data Availability Study: What Do We Really Know About the Safety of High Production Volume Chemicals? Office of Pollution Prevention and Toxics. [Online]. Available: http://www.epa.gov/opptintr/chemtest/hazchem.htm EPA (U.S. Environmental Protection Agency). 1998b. Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), Final Report. Office of Prevention, Pesticides, and Toxic Substances. [Online]. Available: http://www.epa.gov/opptintr/opptendo/finalrpt EPA (U.S. Environmental Protection Agency). 1998c. Health Effects Test Guidelines, OPPTS 870.3800, Reproduction and Fertility Effects. EPA 712-C-98-208, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/ EPA (U.S. Environmental Protection Agency). 1998d. Health Effects Test Guidelines, OPPTS 870.3700, Prenatal developmental Toxicity Study. EPA 712-C-98-207, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/ EPA (U.S. Environmental Protection Agency). 1998e. Health Effects Test Guidelines, OPPTS 870.6300, Developmental Neurotoxicity Study. EPA 712-C-98-239, August 1998. [Online]. Available: http://www.epa.gov/opptsfrs/OPPTS_Harmonized/ EPA (U.S. Environmental Protection Agency). 1998f. EPA Guidelines for Neurotoxicity Risk Assessment FRL-6011-3. NTIS PB98-117831. Effective April 30, 1998. [Online]. Available: http://www.epa.gov/ncea EPA (U.S. Environmental Protection Agency). 1998g. Endocrine Disruptor Screening Program. Fed. Regist. 63(248) ( December 28). Everson, R.B. 1987. A review of approaches to the detection of genetic damage in the human fetus. Environ. Health Perspect. 74:109-117.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Everson, R.B., E. Randerath, T.A. Avitts, H.A. Schut, and K. Randerath. 1987. Preliminary investigations of tissue specificity, species specificity, and strategies for identifying chemicals causing DNA adducts in human placenta. Prog. Exp. Tumor Res. 31:86-103. Everson, R.B., E. Randerath, R.M. Santella, T.A. Avitts, I.B. Weistein, and K. Randerath. 1988. Quantitative associations between DNA damage in human placenta, maternal smoking and birth weight. J. Natl. Cancer Inst. 80(8):567-576. Eyre-Walker, A., and P.D. Keightley. 1999. High genomic deleterious mutation rates in hominids. Nature 397(6717):344-347. Fambrough, D., K. McClure, A. Kazlauskas, and E.S. Lander. 1999. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 97(6):727-741. Fantel, A.G. 1996. Reactive oxygen species in developmental toxicity: Review and hypothesis. [Review]. Teratology 53(3):196-217. Faustman, E.M. 1988. Short-term tests for teratogens. [Review]. Mutat. Res. 205(1-4):355-384. Faustman, E.M., T.A. Lewandowski, R.A. Ponce, and S.M. Bartell. 1999. Biologically cased dose-responce models for developmental toxicants: Lessons from methylmercury. Inhalaton Toxicol. 11:559-572. Faustman, E.M., R.A. Ponce, M.R. Seeley, and S.G. Whittaker. 1997. Experimental approaches to evaluate mechanisms of developmental toxicity. Pp.13-41 in Handbook of Developmental Toxicology, R. Hood, ed. Boca Raton, FL: CRC Press. Faustman, E.M., S.M. Silbernagel, R.A. Fenske, T.M. Burbacher, and R.A. Ponce. 2000. Mechanisms underlying children’s susceptibility to environmental toxicants. Environ. Health Perspect. 108(Suppl.1):13-21. Fawcett, L.B., S.J. Buck, D.A. Beckman, and R.L. Brent. 1996. Is there a no-effect dose for corticosteroid-induced cleft palate? The contribution of endogenous corticosterone to the incidence of cleft palate in mice. Pediatr. Res. 39(5):856-861. FDA (U.S. Food and Drug Administration). 1987. Good Laboratory Practice Regulation for Nonclinical Laboratory Studies, Regulatory Program. 21 CFR 58. FDA (U.S. Food and Drug Administration). 1994. International Conference on Harmonisation: Guideline on Detection of Toxicity to Reproduction for Medicinal Products; Availability. Fed. Regist. 59(183):48746-48752. September 22, 1994. Fekete, D.M. 1999. Development of the vertebrate ear: Insights from knockouts and mutants. Trends Neurosci. 22(6):263-269. Feldman, B., W. Poueymirou, V.E. Papaioannou, T.M. DeChiara, and M. Goldfarb. 1995. Requirement of FGF-4 for postimplantation mouse development. Science 267(5195):246-249. Feng, D-F., G. Cho, and R.F. Doolittle. 1997. Determining divergence times with a protein clock: Update and reevaluation. Proc. Natl. Acad. Sci. U.S.A. 94:13028-13033. Fernandez-Salguero, P.M., D.M. Hilbert, S. Rudikoff, J.M. Ward, and F.J. Gonzalez. 1996. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140(1):173-179. Ferretti, P., and C. Tickle. 1997. The limbs. Pp.101-132 in Embryos, Genes and Birth Defects, P. Thorogood, ed. Chichester: John Wiley & Sons. Fex, G., K. Larsson, A. Andersson, and M. Berggren-Soderlund. 1995. Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate. Possible relation to teratogenicity. Arch. Toxicol. 69(8):572-574. Finnell, R.H., B. Bielec, and H. Nau. 1997a. Anticonvulsant drugs: Mechanisms and pathogenesis of teratogenicity Pp. 121-159 in Drug Toxicity in Embryonic Development II., Handbook of Experimental Pharmacology, Vol. 124/II, R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Finnell, R.H., B.C. Wlodarczyk, J.C. Craig, J.A. Piedrahita, and G.D. Bennett. 1997b. Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse model. Am. J. Med. Genet. 70(3):303-311. Fire, A., S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver, and C.C. Mello. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806-811. Flint, O.P. 1993. In vitro tests for teratogens: Desirable endpoints, test batteries and current status of the micromass teratogen test. [Review]. Reprod. Toxicol. 7(Suppl. 1):103-111. Flint, O.P., and F.T. Boyle. 1985. An in vitro test for teratogens: Its application in the selection of non-teratogenic triazole antifungals. Concepts Toxicol. 3:29-35. Floss, T., H.H. Arnold, and T. Braun. 1997. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11(16):2040-2051. Fong, G.H., J. Rossant, M. Gertsenstein, and M.L. Breitman. 1995. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376(6535):66-70. Fort, D.J., E.L. Stover, J.A. Bantle, J.R. Rayburn, M.A. Hull, R.A. Finch, D.T. Burton, S.D. Turley, D.A. Dawson, G. Linder, D. Buchwalter, M. Kumsher-King, and A.M. Gaudet-Hull. 1998. Phase III interlaboratory study of FETAX, Part 2: Interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay-Xenopus( FETAX). Drug Chem. Toxicol. 21(1):1-14. Francis, N.J., and S.C. Landis. 1999. Cellular and molecular determinants of sympathetic neuron development. Annu. Rev. Neurosci. 22:541-566. Francis, E.Z., C.A. Kimmel, and D.C. Rees. 1990. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: Summary and implications. Neurotoxicol. Teratol. 12(3):285-292. Francis-West, P., R. Ladher, A. Barlow, and A. Graveson. 1998. Signalling interactions during facial development. Mech. Dev. 75(1-2):3-28. Freese, E. 1982. Use of cultured cells in the identification of potential teratogens. Teratog. Carcinog. Mutagen. 2(3-4):355-360. Fretts, R.C., J. Schmittdiel, F.H. McLean, R.H. Usher, and M.B. Goldman. 1995. Increased maternal age and the risk of fetal death. N. Engl. J. Med. 333(15):953-957. Friedman, J.M., and J. E. Polifka. 1994. Teratogenic Effects of Drugs: A Resource for Clinicians: TERIS . Baltimore: Johns Hopkins University Press. 703pp. Galitski, T., A.J. Saldanha, C.A. Styles, E.S. Lander, and G.R. Fink. 1999. Ploidy regulation of gene expression. Science 285(5425):251-254. Gallo, M.A. 1996. History and scope of toxicology. Pp. 3-11 in Casarett and Doull’s Toxicology, The Basic Science of Poisons, 5th Ed., C.D. Klaassen, M.O. Amdur, and J. Doull, eds. New York: McGraw-Hill. Geisler, R., G.J. Rauch, H. Baier, F. van Bebber, L. Brobeta, M.P. Dekens, K. Finger, C. Fricke, M.A. Gates, H. Geiger, S. Geiger-Rudolph, D. Gilmour, S. Glaser, L. Gnugge, H. Habeck, K. Hingst, S. Holley, J. Keenan, A. Kirn, H. Knaut, D. Lashkari, F. Maderspacher, U. Martyn, S. Neuhauss, P. Haffter, et al. 1999. A radiation hybrid map of the zebrafish genome. Nat. Genet. 23(1):86-89. Genbacev, O., T.E. White, C.E. Gavin, and R.K. Miller. 1993. Human trophoblast cultures: Models for implantation and peri-implantation toxicology. Reprod. Toxicol. 7(Suppl. 1):75-94. Generoso, W.M., J.C. Rutledge, K.T. Cain, L.A. Hughes, and P.W. Braden. 1987. Exposure of female mice to ethylene oxide within hours after mating leads to fetal malformation and death. Mutat. Res. 176(2):269-274. Gershon, M.D. 1999a. Endothelin and the development of the enteric nervous system. Clin. Exp. Pharmacol. Physiol. 26(12):985-988. Gershon, M.D. 1999b. Lessons from genetically engineered animal models. II. Disorders of enteric neuronal development: Insights from transgenic mice. Am. J. Physiol. 277(2 Pt. 1):G262-267.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Ortega, S., M. Ittmann, S.H. Tsang, M. Ehrlich, and C. Basilico. 1998. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. U.S.A. 95(10):5672-5677. Ou, Y.C., S.A. Thompson, S.C. Kirchner, T.J. Kavanagh, and E.M. Faustman. 1997. Induction of growth arrest and DNA damage-inducible genes Gadd45 and Gadd153 in primary rodent embryonic cells following exposure to methylmercury. Toxicol. Appl. Pharmacol. 147(1):31-38. Ou, Y.C., S.A. Thompson, R.A. Ponce, J. Schroeder, T.J. Kavanagh, and E.M. Faustman. 1999. Induction of the cell cycle regulatory gene p21 (Waf1, Cip1) following methylmercury exposure in vitro and in vivo. Toxicol. Appl. Pharmacol. 157(3):203-212. Oudenampsen, E., E.M. Kupsch, T. Wissel, F. Spener, and A. Lezius. 1990. Expression of fatty acid-binding protein from bovine heart in Escherichia coli. Mol. Cell Biochem. 98(1-2):75-79. Pace, N.R. 1997. A molecular view of microbial diversity and the biosphere. Science 276(5313): 734-740. Padgett, R.W., P. Das, and S. Krishna. 1998. TGF-beta signaling, Smads, and tumor suppressors. BioEssays 20:382-391. Park, S., J. Frisen, and M. Barbacid. 1997. Aberrant axonal projections in mice lacking EphA8 (Eek) tyrosine protein kinase receptors. EMBO J. 16(11):3106-3114. Palmiter, R.D., E.P. Sandgren, M.R. Avarbock, D.D. Allen, and R.L. Brinster. 1991. Heterologous introns can enhance expression of transgenes in mice. Proc. Natl. Acad. Sci. U.S.A. 88(2): 478-482. Parker, K.L., A. Schedl, and B.P. Schimmer. 1999. Gene interactions in gonadal development. Annu. Rev. Physiol. 61:417-433. Parsons, J.F., J. Rockley, and M. Richold. 1990. In-vitro micromass teratogen test- interpretation of results from a blind trial of 25 compounds using 3 separate criteria. Toxicol. in Vitro 4(4-5):609-611. Payne, J., F. Shibasaki, and M. Mercola. 1997. Spina bifida occulta in homozygous Patch mouse embryos. Dev. Dyn. 209(1):105-116. Pennisi, E. 1997. A catalog of cancer genes at the click of a mouse. Science 276(5315):1023-1024. Perera, F.P., R.M. Whyatt, W. Jedrychowski, V. Rauh, D. Manchester, R.M. Santella, and R. Ottman. 1998. Recent developments in molecular epidemiology. A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am. J. Epidem. 147(3): 309-314. Perrimon, N., and A.P. McMahon. 1999. Negative feedback mechanisms and their roles during pattern formation. Cell 97(1):13-16. Perrimon, N., L. Engstrom, and A.P. Mahowald. 1989. Zygotic lethals with specific maternal effect phenotypes in Drosophila melanogaster. I. Loci on the X chromosome. Genetics 121:333-352. Peterka, M., and T. Pexieder. 1994. Embryotoxicity and teratogenicity of all-trans retinoic acid in chick embryo. Teratology 50(5):39A. Peters, H., and R. Balling. 1999. Teeth. Where and how to make them. Trends Genet. 15(2):59-65. Peterson, L.A., M.R. Brown, A.J. Carlisle, E.C. Kohn, L.A. Liotta, M.R. Emmert-Buck, and D.B. Krizman. 1998. An improved method for construction of directionally cloned cDNA libraries from microdissected cells. Cancer Res. 58(23):5326-5328. Petrini, J., K. Damus, and R.B. Johnston, Jr. 1997. An overview of infant mortality and birth defects in the United States. Teratology 56(1/2):8-9. Philippe, A., M. Martinez, M. Guilloud-Bataille, C. Gillberg, M. Rastam, E. Sponheim, M. Coleman, M. Zappella, H. Aschauer, L. van Malldergerme, C. Penet, J. Feingold, A. Brice, and M. Leboyer. 1999. Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study. Hum. Mol. Genet. 8(5):805-812. Pichel, J.G., L. Shen, H.Z. Sheng, A.C. Granholm, J. Drago, A. Grinberg, E.J. Lee, S.P. Huang, M. Saarma, B.J. Hoffer, H. Sariola, and H. Westphal. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382(6586):73-76.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Pignatello, M.A., F.C. Kauffman, and A.A. Levin. 1999. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): Interactions with the retinoic acid receptors. Toxicol. Appl. Pharmacol. 159(2):109-116. Plasterk, R.H.A. 1995. Reverse genetics: From gene sequence to mutant worm. Pp. 59-80 in Methods in Cell Biology, Vol. 48, Caenorhabditis elegans: Modern Biological Analysis of an Organism, H.F. Epstein, and D.C. Shakes, eds. San Diego, CA: Academic Press. Poland, A., D. Palen, and E. Glover. 1994. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 46(5):915-921. Ponce, R.A., T.J. Kavanagh, N.K. Mottet, S.G. Whittaker, and E.M. Faustman. 1994. Effects of methyl mercury on the cell cycle of primary rat CNS cells in vitro. Toxicol. Appl. Pharmacol. 127(1):83-90. Porter, J.A., K.E. Young, and P.A. Beachy. 1996. Cholesterol modification of hedgehog signaling proteins in animal development. Science 274(5285):255-259. Powell-Braxton, L., P. Hollingshead, C. Warburton, M. Dowd, S. Pitts-Meek, D. Dalton, N. Gillett, and T.A. Stewart. 1993. IGF-I is required for normal embryonic growth in mice. Genes Dev. 7(12B):2609-2617. Powell-Coffman, J.A., C.A. Bradfield, and W.B. Wood. 1998. Caenorhabditis elegans orthologs of the aryl hydrocarbon receptor and its heterodimerization partner the aryl hydrocarbon receptor nuclear translocator. Proc. Natl. Acad. Sci. U.S.A. 95:2844-2849. Quig, D. 1998. Cysteine metabolism and metal toxicity. Altern. Med. Rev. 3(4):262-270. Radatz, M., K. Ehlers, B. Yagen, M. Bialer, and H. Nau. 1998. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid. Epilepsy Res. 30(1):41-48. Raftery, L.A., V. Twombly, K. Wharton, and W.M. Gelbart. 1995. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics 139:241-254. Rawls, A., J. Wilson-Rawls, and E.N. Olson. 2000. Genetic regulation of somite formation. Curr. Top. Dev. Biol. 47:131-154. Reiners, J., W. Wittfoht, H. Nau, R. Vogel, B. Tenschert, and H. Spielmann 1987. Teratogenesis and pharmacokinetics of cyclophosphamide after drug infusion as compared to injection in the mouse during day 10 of gestation. Pp. 41-48 in Pharmacokinetics in Teratogenesis, Vol. II, H. Nau, and W. Scott, eds. Boca Raton, FL: CRC Press. Reinhardt, C.A. 1993. Neurodevelopmental toxicity in vitro: Primary cell culture models for screening and risk assessment [Review]. Reprod. Toxicol. 7(Suppl. 1):165-170. Reichhardt, T. 1999. It’s sink or swim as a tidal wave of data approaches. Nature 399(6736):517-520. Relaix, F., and M. Buckingham. 1999. From insect eye to vertebrate muscle: Redeployment of a regulatory network. Genes Dev. 13(24):3171-3178. Renwick, A.G. 1998. Toxicokinetics in infants and children in relation to the ADI and TDI. Food Addit. Contam. 15(Suppl.):17-35. Riddle, D.L., and P.S. Albert. 1997. Genetic and environmental regulation of dauer larva development. Pp. 739-768 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press. Riddle, D.L., T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. 1997. C. elegans II. Plainview, NY: Cold Spring Harbor Laboratory Press. 1222 pp. Robert, E. 1992. Detecting new teratogens: Valproic acid. Teratology 45(3):331. Rodier, P.M. 1998. Neuroteratology of autism. Pp. 661-672 in Handbook of Developmental Neurotoxicology, W. Slikker, and L. Chang, eds. New York: Academic Press. Rodier, P.M. 2000. The early origins of autism. Sci. Am. 282:56-63. Rodier, P.M., M. Aschner, and P.R. Sager. 1984. Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. Neurobehav. Toxicol. Teratol. 6(5):379-385. Rodier, P.M., S.E. Bryson, and J.P. Welch. 1997. Minor malformations and physical measurements in autism: Data from Nova Scotia. Teratology 55(5):319-325.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Rodier, P.M., J.L. Ingram, B. Tisdale, S. Nelson, and J. Romano. 1996. Embryological origin for autism: Developmental anomalies of the cranial nerve motor nuclei. J. Comp. Neurol. 370(2):247-261. Roelink, H., J.A. Porter, C. Chiang, Y. Tanabe, D.T. Chang, P.A. Beachy, and T.M. Jessell. 1995. Floor plate and motor neuron induction by different concentrations of the amino-terminal cleavage product of sonic hedgehog autoproteolysis. Cell 81(3):445-455. Rosa, F.W. 1992. Epidemiology of drugs in pregnancy. Pp. 97-106 in Pediatric Pharmacology, 2nd Ed., S.J. Yaffe, and J.V. Aranda, eds. Philadelphia, PA: Saunders. Rothman, K.J. 1986. Modern Epidemiology. Boston: Little, Brown. Roux, C., and M. Aubry. 1966. Teratogenic action in the rat of an inhibitor of cholesterol synthesis, AY 9944 [in French]. C. R. Seances Soc. Biol. Fil. 160(7):1353-1357. Rudner, A.D., and A.W. Murray. 1996. The spindle assembly checkpoint. Curr. Opin. Cell Biol. 8(6):773-780. Rutherford, S.L., and S. Lindquist. 1998. Hsp90 as a capacitor for morphological evolution. Nature 396(6709):336-342. Rutledge, J.C. 1997. Developmental toxicity induced during early stages of mammalian embryogenesis. Mutat. Res. 396(1-2):113-127. Rutledge, J.C., A.G. Shourbaji, L.A. Hughes, J.E. Polifka, Y.P. Cruz, J.B. Bishop, and W.M. Generoso. 1994. Limb and lower-body duplications induced by retinoic acid in mice. Proc. Natl. Acad. Sci. U.S.A. 91(12):5436-5440. Ruvkun, G. 1997. Patterning the nervous system. Pp. 543-581 in C. elegans II, D.L. Riddle, T. Blumenthal, B.J. Meyer, and J.R. Priess, eds. Plainview, NY: Cold Spring Harbor Laboratory Press. Ruvkun, G., and O. Hobert. 1998. The taxonomy of developmental control in Caenorhabditis elegans. Science 282(5396):2033-2041. Saint-Amant, L., and P. Drapeau. 1998. Time course of the development of motor behaviors in the zebrafish embryo. J. Neurobiol. 37(4):622-632. Salvesen, G.S. 1999. Programmed cell death and the caspases. APMIS 107(1):73-79. Sanchez, M.P., I. Silos-Santiago, J. Frisen, B. He, S.A. Lira, and M. Barbacid. 1996. Renal agenesis and the absence of enteric neurons in mice lacking GDNF . Nature 382(6586):70-73. Sanford, L.P., I. Ormsby, A.C. Gittenberger-de Groot, H. Sariola, R. Friedman, G.P. Boivin, E.L. Cardell, and T. Doetschman. 1997. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 124(13):2659-2670. Sariola, H., and K. Sainio. 1998. Cell lineages in the embryonic kidney: Their inductive interactions and signalling molecules. Biochem. Cell Biol. 76(6):1009-1016. Saxton, T.M., M. Henkemeyer, S. Gasca, R. Shen, D.J. Rossi, F. Shalaby, G.S. Feng, and T. Pawson. 1997. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16(9):2352-2364. Schardein, J.L. 2000. Chemically Induced Birth Defects, 3th Ed. New York: Marcel Dekker. Schilling, T.F., T. Piotrowski, H. Grandel, M. Brand, C.P. Heisenberg, Y.J. Jiang, D. Beuchle, M. Hammerschmidt, D.A. Kane, M.C. Mullins, F.J. van Eeden, R.N. Kelsh, M. Furutani-Seiki, M. Granato, P. Haffter, J. Odenthal, R.M. Warga, T. Trowe, and C. Nüsslein-Volhard. 1996. Jaw and branchial arch mutants in zebrafish I: branchial arches. Development 123:329-344. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birshmeier. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373(6516):699-702. Schneider, R.A., D. Hu, and J.A. Helms. 1999. From head to toe: Conservation of molecular signals regulating limb and craniofacial morphogenesis. Cell Tissue Res. 296(1):103-109.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Schuchardt, A., V. D’Agati, L. Larsson-Blomberg, F. Costantini, and V. Pachnis. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367(6461):380-383. Schuchardt, A., V. D’Agati, V. Pachnis, and F. Costantini. 1996. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 122(6): 1919-1929. Schwartz, E.L., S. Hallam, R.E. Gallagher, and P.H. Wiernik. 1995. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia. Biochem. Pharmacol. 50(7):923-928. Schwetz, B.A. 1993. In vitro approaches in developmental toxicology. [Review]. Reprod. Toxicol. 7(Suppl. 1):125-127. Schwetz, B.A., and M.W. Harris. 1993. Developmental toxicology: Status of the field and contribution of the National Toxicology Program. [Review]. Environ. Health Perspect. 100:269-282. Scott, W.J. 1977. Cell death and reduced proliferation rate. Pp. 81-98 in Handbook of Teratology, Vol. 2., J.G. Wilson, and F.C. Fraser, eds. New York: Plenum. Selevan, S.G. 1985. Design of pregnancy outcome studies of industrial exposures. Pp. 219-229 in Occupational Hazards and Reproduction, K. Hemminki, M. Sorsa, and H. Vainio, eds. Washington, DC: Hemishere Pub. Sever, L., M.C. Lynberg, and L.D. Edmonds. 1993. The impact of congenital malformations on public health. Teratology 48(6):547-549. Shaw, G.M., C.R. Wasserman, E.J. Lammer, C.D. O’Malley, J.C. Murray, A.M. Basart, and M.M. Tolarova. 1996. Orofacial clefts, parental cigarette smoking and transforming growth factor-alpha gene variants. Am. J. Hum. Genet. 58:551-561. Shepard, T.H. 1998. Catalog of Teratogenic Agents. 9th Ed. Baltimore: Johns Hopkins University Press. 593 pp. Shepard, T.H., A.G. Fantel, P.E. Mirkes, J.C. Greenaway, E. Faustman-Watts, M. Campbell, and M.R. Juchau. 1983. Teratology testing: I. Development and status of short-term prescreens. II. Biotransformation of teratogens as studied in whole embryo culture. Prog. Clin. Biol. Res. 135:147-164. Shuey, D.L., R.W. Setzer, C. Lau, R.M. Zucker, K.H. Elstein, M.G. Narotsky, R.J. Kavlock, and J.M. Rogers. 1995. Biological modeling of 5-fluorouracil developmental toxicity. Toxicology 102(1-2):207-213. Shum, S., N.M. Jensen, and D.W. Nebert. 1979. The murine Ah locus: In utero toxicity and teratogenesis associated with genetic differences in benzo[a]pyrene metabolism. Teratology 20(3): 365-376. Sibilia, M., and E.F. Wagner. 1995. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269(5221):234-238. Sidrauski, C., R. Chapman, and P. Walter. 1998. The unfolded protein response: An intracellular signalling pathway with many surprising features. Trends Cell. Biol. 8(6):245-249. Silver, L.M. 1995. Mouse Genetics: Concepts and Applications. New York: Oxford University Press. 362pp. Simone, N.L., R.F. Bonner, J.W. Gillespie, M.R. Emmert-Buck, and L.A. Liotta. 1998. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis. Trends Genet. 14(7):272-276. Simon, M.A., D.D. Bowtell, G.S. Dodson, T.R. Laverty, and G.M. Rubin. 1991. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase. Cell 67(4):701-716. Sleet, R.B., and K. Brendel. 1985. Homogeneous populations of Artemia nauplii and their potential use for in vitro testing in developmental toxicology. Teratog. Carcinog. Mutagen. 5(1):41-54.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Slikker, W., and R.K. Miller. 1994. Placental metabolism and transfer, role in developmental toxicology. Pp. 245-283 in Developmental Toxicology, 2nd Ed., C. Kimmel, and J. Buelke-Sam, eds. New York: Raven Press. Smeyne, R.J., R. Klein, A. Schnapp, L.K. Long, S. Bryant, A. Lewin , S.A. Lira, and M. Barbacid. 1994. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368(6468):246-249. Smith, J.L., and G.C. Schoenwolf. 1998. Getting organized: New insights into the organizer of higher vertebrates. Curr. Top. Dev. Biol. 40:79-110. Smith, M.K., G.L. Kimmel, D.M. Kochhar, T.H. Shepard, S.P. Spielberg, and J.G. Wilson. 1983. A selection of candidate compounds for in vitro teratogenesis test validation. Teratog. Carcinog. Mutagen. 3(6):461-480. Snow, E.T. 1997. The role of DNA repair in development. Reprod. Toxicol. 11(2/3):353-365. Soriano, P. 1997. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 124(14):2691-2700. Spellman, P.T., G. Sherlock, M.Q. Zhang, V.R. Iyer, K. Anders, M.B. Eisen, P.O. Brown, D. Botstein, and B. Futcher. 1998. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9(12):3273-3297. Spemann, H., and H. Mangold. 1924. Über Induktion von Embryonalanlagen durch Implatation artfremder Organisatoren. [in German]. Arch. f. Mikr. Anat. u. Entw.-Mech. 100:599-638. Spence, S., C. Anderson, M. Cukierski, and D. Patrick. 1999. Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod. Toxicol. 13(1):15-29. Spiegelstein, O., M. Bialer, M. Radatz, H. Nau, and B. Yagen. 1999. Enantioselective synthesis and teratogenicity of propylisopropyl acetamide, a CNS-active chiral amide analogue of valproic acid. Chirality 11(8):645-650. Spielmann, H., I. Pohl, B. Doring, M. Liebsch, and F. Moldenhauer. 1997. The embryonic stem cell test, an in vitro embryotoxicity test using two permanent mouse cell lines: 3T3 fibroblasts and embryonic stem cells. In Vitro Toxicol. 10(1):119-127. Spielmann, H., G. Scholtz, A. Seiler, I. Pohl, S. Bremer, N. Brown, and A. Piersma. 1998. Ergebnisse der ersten Phase des ECVAM-Projektes zur Prävalidierung und Validierung von drei in vitro Embryotoxizitätstests. [in German]. ALTEX 15:3-8. Stainier, D.Y., and M.C. Fishman. 1992. Patterning the zebrafish heart tube: Acquisition of anteroposterior polarity. Dev. Biol. 153(1):91-101. Stainier, D.Y., B. Fouquet, J.N. Chen, K.S. Warren, B.M. Weinstein, S.E. Meiler, M.A. Mohideen, S.C. Neuhauss, L. Solnica-Krezel, A.F. Schier, F. Zwartkruis, D.L. Stemple, J. Malicki, W. Driever, and M.C. Fishman. 1996. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 123:285-292. Stearnes, S.C. 1989. The evolutionary significance of phenotypic plasticity. Bioscience 39(7): 436-445. Steele, V.E., R.E. Morrissey, E.L. Elmore, D. Gurganus-Rocha, B.P. Wilkinson, R.D. Curren, B.S. Schmetter, A.T. Louie, J.C. Lamb, IV, and L.L. Yang. 1988. Evaluation of two in vitro assays to screen for potential developmental toxicants. Fundam. Appl. Toxicol. 11(4):673-684. Stephens, T.D. 1988. Proposed mechanisms of action in thalidomide embryopathy. Teratology 38(3):229-239. Stephens, T.D., and B.J. Fillmore. 2000. Hypothesis: Thalidomide embryopathy—proposed mechanism of action. Teratology 61(3):189-195. Sternberg, P.W., and H.R. Horvitz. 1991. Signal transduction during C. elegans vulval induction. Trends Genet. 7(11/12):366-371. Stodgell, C.J., L.L. Knauber, J.L. Ingram, S.L. Hyman, D.A. Figlewicz, and P.M. Rodier. 1999. A structural variant of HOXA1 associated with autism. [Abstract]. Teratology 59:389. Stohs, S.J., and D. Bagchi. 1995. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 18(2):321-336.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment St-Onge, L., R. Wehr, and P. Gruss. 1999. Pancreas development and diabetes. Curr. Opin. Genet. Dev. 9(3):295-300. Storm, E.E., and D.M. Kingsley. 1996. Joint patterning defects caused by single and double mutations in members of the bone morphogenetic protein (BMP) family. Development 122(12):3969-3979. Streissguth, A.P., and P. Dehaene. 1993. Fetal alcohol syndrome in twins of alcoholic mothers: Concordance of diagnosis and IQ. Am. J. Med. Genet. 47(6):857-861. Strom, B.L., ed. 1994. Systems available for pharmacoepidemiology studies. Pp 125-337 in Pharmacoepidemiology, 2nd Ed. New York: John Wiley & Sons. Strömland, K., V. Nordin, M. Miller, B. Akerstrom, and C. Gillberg. 1994. Autism in thalidomide embryopathy: A population study. Dev. Med. Child Neurol. 36(4):351-356. Studer, M., A. Lumsden, L. Ariza-McNaughton, A. Bradley, and R. Krumlauf. 1996. Altered segmental identity and abnormal migration of motor neurons in mice lacking Hoxb-1. Nature 384(6610):630-634. Sucov, H.M., E. Dyson, C.L. Gumeringer, J. Price, K.R. Chien, and R.M. Evans. 1994. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev. 8(9):1007-1018. Sucov, H.M., J.C. Izpisua-Belmonte, Y. Ganan, and R.M. Evans. 1995. Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 121(12):3997-4003. Sugrue, S.P., and J.M. DeSesso. 1982. Altered glycosaminoglycan composition of rat forelimb-buds during hydroxyurea teratogenesis: An indication of repair. Teratology 26(1):71-83. Sullivan, F.M., S.E. Smith, and P.R. McElhatton 1987. Interpretation of animal experiments as illustrated by studies on caffeine. Pp.123-130 in Pharmacokinetics in Teratogenesis, Vol. I. Interspecies Comparison and Maternal/Embryonic-Fetal Drug Transfer, H. Nau, and W. Scott, eds. Boca Raton, FL: CRC Press. Sulston, J.E., and H.R. Horvitz. 1977. Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev. Biol. 56(1):110-156. Sulston, J.E., E. Schierenberg, J.G. White, and J.N. Thomson. 1983. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 100:64-119. Summerbell, D., and P.W. Rigby. 2000. Transcriptional regulation during somitogenesis. Curr. Top. Dev. Biol. 48:301-318. Suzuki, Y., M.D. Yandell, P.J. Roy, S. Krishna, C. Savage-Dunn, R.M. Ross, R.W. Padgett, and W.B. Wood. 1999. A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. Development 126(2):241-250. Swain, A., and R. Lovell-Badge. 1999. Mammalian sex determination: A molecular drama. Genes Dev. 13(7):755-767. Swiatek, P.J., C.E. Lindsell, F.F. del Amo, G. Weinmaster, and T. Gridley. 1994. Notch1 is essential for postimplantation development in mice. Genes Dev. 8(6):707-719. Tabin, C.J. 1998. A developmental model for thalidomide defects. Nature 396(6709):322-323. Takahashi, J.S. 1995. Molecular neurobiology and genetics of circadian rhythms in mammals. Annu. Rev. Neurosci. 18:531-553. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. U.S.A. 94(8):3801-3804. Tallquist, M.D., P. Soriano, and R.A. Klinghoffer. 1999. Growth factor signaling pathways in vascular development. Oncogene 18(55):7917-7932. Tamayo, P., D. Slonim, J. Mesirov, Q. Zhu, S. Kitareewan, E. Dmitrovsky , E.S. Lander, and T.R. Golub. 1999. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation. Proc. Natl. Acad. Sci. U.S.A. 96(6):2907-2912.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Tanabe, Y., and T.M. Jessell. 1996. Diversity and pattern in the developing spinal cord. Science 274(5290):1115-1123. Taubes, G. 1995. Epidemiology faces its limits. Science 269:164-169. Terry, K.K., B.A. Elswick, D.B. Stedman, and F. Welsch. 1994. Developmental phase alters dosimetry-teratogenicity relationship for 2-methoxyethanol in CD-1 mice. Teratology 49:218-227. Threadgill, D.W., A.A. Dlugosz, L.A. Hansen, T. Tennenbaum, U. Lichti, D. Yee, C. LaMantia, T. Mourton, K. Herrup, R.C. Harris, et al. 1995. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269(5221):230-234. Tillner, J., T. Winckler, and T. Dingermann. 1996. Developmentally regulated promoters from Dictyostelium discoideum as molecular markers for testing potential teratogens. Pharmazie. 51(11):902-906. Tint, G.S., M. Irons, E.R. Elias, A.K. Batta, R. Frieden, T.S. Chen, and G. Salen. 1994. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N. Engl. J. Med. 330(2):107-113. Toraason, M., J.S. Bohrman, E. Krieg, R.D. Combes, S.E. Willington, W. Zajac, and R. Langenbach. 1992. Evaluation of the V79 cell metabolic cooperation assay as a screen in vitro for developmental toxicants. Toxicol. in Vitro 6(2):165-174. Treinen, K.A., C. Louden, M.J. Dennis, and P.J. Wier. 1999. Developmental toxicity and toxicokinetics of two endothelin receptor antagonists in rats and rabbits. Teratology 59(1):51-59. Trofimova-Griffin, M.E., M.R. Brzezinski, and M.R. Juchau. 2000. Patterns of CYP26 expression in human prenatal cephalic and hepatic tissues indicate an important role during early brain development. Brain Res. Dev. Brain Res. 120(1):7-16. Tucker, A.S., and P.T. Sharpe. 1999. Molecular genetics of tooth morphogenesis and patterning: The right shape in the right place. J. Dent. Res. 78(4):826-834. Turner, M., P.J. Mee, A.E. Walters, M.E. Quinn, A.L. Mellor, R. Zamoyska, and V.L. Tybulewicz. 1997. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7(4):451-460. Tzimas, G., R. Thiel, I. Chahoud, and H. Nau. 1997. The area under the concentration-time curve of all-trans-retinoic acid is the most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat. Toxicol. Appl. Pharmacol. 143:436-444. Umanoff, H., W. Edelmann, A. Pellicer, and R. Kucherlapati. 1995. The murine N-ras gene is not essential for growth and development. Proc. Natl. Acad. Sci. U.S.A. 92(5):1709-1713. Uphill, P.F., S.R. Wilkins, and J.A. Allen. 1990. In vitro Micromass Teratogen Test - results from a blind trial of 25 compounds. Toxicol. in Vitro 4(4-5):623-626. Vaglia, J.L., and B.K. Hall. 1999. Regulation of neural crest cell populations: Occurrence, distribution and underlying mechanisms. Int. J. Dev. Biol. 43(2):95-110. Van den Berg, M., L. Birnbaum, A.T.C. Bosveld, B. Brunstrom, P. Cook, M. Feeley, J.P. Giesy, A. Hanberg, R. Hasegawa, S.W. Kennedy, T. Kubiak, J.C. Larsen, F.X. van Leeuwen, A.K. Liem, C. Nolt, R.E. Peterson, L. Poellinger, S. Safe, D. Schrenk, D. Tillitt, M. Tysklind, M. Younes, F. Waern, and T. Zacharewski. 1998. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ. Health Perspect. 106(12):775-792. van Dyke, D.C., S.E. Hodge, F. Heide, and L.R. Hill. 1988. Family studies in fetal phenytoin exposure. J. Pediatr. 113(2):301-306. Vanden Bossche, H., G. Willemsens, and P.A. Janssen. 1988. Cytochrome-P-450-dependent metabolism of retinoic acid in rat skinmicrosomes: Inhibition by ketoconazole. Skin Pharmacol. 1(3):176-185. Vasicek, T.J., L. Zeng, X.J. Guan, T. Zhang, F. Costantini, and S.M. Tilghman. 1997. Two dominant mutations in the mouse fused gene are the result of transposon insertions. Genetics 147(2): 777-786. Velie, E.M., and G.M. Shaw. 1996. Impact of prenatal diagnosis and elective termination on prevalence and risk estimates of neural tube defects in California, 1989-1991. Am. J. Epidemiol. 144(5):473-479.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Ventura, S.J., J.A. Martin, S.C. Curtin, and T.J. Matthews. 1997. Report of Final Natality Statistics. Hyattsville, MD: U.S. Department of Health and Human Services, CDC, National Center for Health Statistics, 45(11) Suppl. 2. PHS 97-1120. Veraksa, A., M. Del Campo, and W. McGinnis. 2000. Developmental patterning genes and their conserved functions: From model organisms to humans. Mol. Genet. Metab. 69(2):85-100. Vogel, D.G., P.S. Rabinovitch, and N.K. Mottet. 1986. Methylmercury effects on cell cycle kinetics. Cell Tissue Kinet. 19(2):227-242. Vogt, T.F., and D. Duboule. 1999. Antagonists go out on a limb. Cell 99(6):563-566. Waitzman, N.J., P.S. Romano, and R.M. Scheffler. 1994. Estimates of the economic costs of birth defects. Inquiry 31(2):188-205. Wakayama, T., and R. Yanagimachi. 1999a. Cloning of male mice from adult tail-tip cells. Nat. Genet. 22(2):127-128. Wakayama, T., and R. Yanagimachi. 1999b. Cloning the laboratory mouse. Semin. Cell Dev. Biol. 10(3):253-258. Wakayama, T., A.C. Perry, M. Zuccotti, K.R. Johnson, and R. Yanagimachi. 1998. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature 394(6691): 369-374. Wakayama, T., I. Rodriguez, A.C. Perry, R. Yanagimachi, and P. Mombaerts. 1999. Mice cloned from embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 96(26):14984-14989. Walker, B.E., and M.I. Haven. 1997. Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis 18(4):791-793. Walmod, P.S., A. Foley, A. Berezin, U. Ellerbeck, H. Nau, E. Bock, and V. Berezin. 1998. Cell motility is inhibited by the antiepileptic compound, valproic acid and its teratogenic analogues . Cell Motil. Cytoskeleton 40(3):220-237. Walmod, P.S., G. Skladchikova, A. Kawa, V. Berezin, and E. Bock. 1999. Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton. Cell Motil. Cytoskeleton. 42(3):241-255. Walton, B.T. 1983. Use of the cricket embryo (Acheta domesticus) as an invertebrate teratology model. Fundam. Appl. Toxicol. 3(4):233-236. Wang, Y.L., and N.A. Brown. 1994. Expression patterns of Hox-B1, -B2 and Krox 20 in triazole-treated rat embryos suggest rhombomere reductions and loss. Teratology 49:380. Wang, Z.Q., M.R. Fung, D.P. Barlow, and E.F. Wagner. 1994. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372(6505):464-467. Wang, Z.Q., C. Ovitt, A.E. Grigoriadis, U. Mohle-Steinlein, U. Ruther, and E.F. Wagner. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360(6406):741-745. Warburton, D., and M.K. Lee. 1999. Current concepts on lung development. Curr. Opin. Pediatr. 11(3):188-192. Warkany, J. 1978. Teratogen update: Aminopterin and methotrexate. Folic acid deficiency. Teratology 17(Jan.):353-358. Wassef, M., and A.L. Joyner. 1997. Early mesencephalon/metencephalon patterning and development of the cerebellum. Perspect. Dev. Neurobiol. 5(1):3-16. Wasteneys, G.O., M. Cadrin, K.R. Reuhl, and D.L. Brown. 1988. The effects of methylmercury on the cytoskeleton of murine embryonal carcinoma cells. Cell Biol. Toxicol. 4(1):41-60. Webster, W.S., P.D. Brown-Woodman, and H.E. Ritchie. 1997. A review of the contribution of whole embryo culture to the determination of hazard and risk in teratogenicity testing. Int. J. Dev. Biol. 41(2):329-335. Webster, W.S., P.D. Brown-Woodman, M.D. Snow, and B.R. Danielsson. 1996. Teratogenic potential of almokalant, dofetilide, and d-sotalol: Drugs with potassium channel blocking activity. Teratology 53(3):168-175. Weiner, A.J., M.P. Scott, and T.C. Kaufman. 1984. A molecular analysis of fushi tarazu, a gene in Drosophila melanogaster that encodes a product affecting embryonic segment number and cell fate. Cell 37(3):843-851.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Weinstein, D.C., and A. Hemmati-Brivanlou. 1999. Neural induction. Annu. Rev. Cell. Dev. Biol. 15:411-433. Weinstein, M., X. Xu, K. Ohyama, and C.X. Deng. 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125(18):3615-3623. Weiss, S.R., C.E. Cooke, L.R. Bradley, and J.M. Manson. 1999. Pharmacist’s guide to pregnancy registry studies. J. Am. Pharm. Assoc. 39(6):830-834. Welch, R.M., Y.E. Harrison, B.W. Gommi, P.J. Poppers, M. Finster, and A.H. Conney. 1969. Stimulatory effect of cigarette smoking on the hydroxylation of 3,4-benzo(a)pyrene and the N-demethylation of 3-methyl-4-monomethylamino-azobenzene by enzymes in human placenta. Clin. Pharm. Therap. 10(1):100-110. Welch, W.J. 1991. The role of heat-shock proteins as molecular chaperones. Curr. Opin. Cell Biol. 3(6):1033-1038. Weller, E., N. Long, A. Smith, P. Williams, S. Ravi, J. Gill, R. Henessey, W. Skornik, J. Brain, C. Kimmel, G. Kimmel, L. Holmes, and L. Ryan. 1999. Dose-rate effects of ethylene oxide exposure on developmental toxicity. Toxicol. Sci. 50(2):259-270. Wellfelt, K., A.C. Skold, A. Wallin, and B.R. Danielsson. 1999. Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species. Reprod. Toxicol. 13(2):93-101. Wells, P.G., and L.M. Winn. 1996. Biochemical toxicology of chemical teratogenesis. Crit. Rev. Biochem. Mol. Biol. 31(1):1-40. Wells, P.G., P.M. Kim, C.J. Nicol, T. Parman, and L.M. Winn. 1997. Reactive intermediates. Pp. 451-516 in Drug Toxicity in Embryonic Development, Vol 1., Handbook of Experimental Pharmacology , Vol. 124/I, R.J. Kavlock, and G.P. Daston, eds. Heidelberg: Springer. Wells, P.G, J.T. Zubovits, S.T. Wong, L.M. Molinari, and S. Ali. 1989. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: Implications for bioactivation by prostaglandin synthetase. Toxicol. Appl. Pharmacol. 97(2):192-202. Welsch, F. 1992. In vitro approaches to the elucidation of mechanisms of chemical teratogenesis. [Review]. Teratology 46(1):3-14. Welsch, F., G.M. Blumenthal, and R.B. Conolly. 1995. Physiologically based pharmacokinetic models applicable to organogenesis: Extrapolation between species and potential use in prenatal toxicity risk assessments. Toxicol. Lett. 82/83:539-547. Welsch, F., K.K. Terry, D.B. Stedman, and B.A. Elswick. 1996. Linking embryo dosimetry and teratogenic responses to 2-methoxyethanol at different stages of gestation in mice. Occupat. Hyg. 2:121-130. Wilcox, A.J., D.D. Baird, and C.R. Weinberg. 1999. Time of implantation of the conceptus and loss of pregnancy. N. Engl. J. Med. 340(23):1796-1799. Willhite, C.C., P.J. Wier, and D.L. Berry. 1989. Dose response and structure-activity considerations in retinoid-induced dysmorphogenesis. Crit. Rev. Toxicol. 20(2):113-135. Wilmut, I., A.E. Schnieke, J. McWhir, A.J. Kind, and K.H. Campbell. 1997. Viable offspring derived from fetal and adult mammalian cells. Nature 385(6619):810-813. Wilson, C.L., and S. Safe. 1998. Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 26(5):657-671. Wilson, J.G. 1973. Environment and Birth Defects. New York: Academic Press. 305 pp. Wilson, J.G., and F.C. Fraser. 1977. Handbook of Teratology. New York: Plenum Press. Wilson, K.L., L.M. Cornel, and P.E. Mirkes. 1999. Teratogen-induced activation of mitogen-activated protein kinases (MARKs) in postimplantation embryos. Teratology 59:385-386. Winter, R.M. 1996. Analysing human developmental abnormalities. Bioessays 18(12):965-971. Wise, L.D., R.L. Clark, J.O. Rundell, and R.T. Robertson. 1990. Examination of a rodent limb bud micromass assay as a prescreen for developmental toxicity. Teratology 41(3):341-351.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment Wlodarczyk, B.C., J.C. Craig, G.D. Bennett, J.A. Calvin, and R.H. Finnell. 1996. Valproic acid-induced changes in gene expression during neurulation in a mouse model. Teratology 54(6):284-297. Wolpert, L. 1969. Positional information and the spatial pattern of cellular differentiation. J. Theor. Biol. 25(1):1-47. Wolpert, L., R. Beddington, J. Brockes, T. Jessell, P. Lawrence, and E. Mayerowitz. 1998. P. 484 in Principles of Development. New York: Current Biology. Wood, W.B. 1998. Cell lineages in Caenorhabditis elegans development. Pp. 77-95 in Cell Lineage and Fate Determination, S.A. Moody, ed. San Diego, CA: Academic Press. Wood, W.B. 1999. Caenorhabditis. Pp. 324 in Encyclopedia of Molecular Biology, T.E. Creighton, ed. New York: Wiley. Wood, W. B. et al., eds. 1988. The Nematode Caenorhabditis elegans. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press. 667 pp. Wubah, J.A., M.M. Ibrahim, X. Gao, D. Nguyen, M.M. Pisano, and T.B. Knudsen. 1996. Teratogen-induced eye defects mediated by p53-dependent apoptosis. Curr. Biol. 6(1):60-69. Wubah, J.A., C.A. Kimmel, G.L. Kimmel, R.J. Kavlock, C. Lau, R.W. Setzer, and T.B. Knudsen. 1997. Pax6 expression, a biomarker of teratogen-induced abnormalities of the eye. Teratology 55(1):33. Xu, T., and S. Artavanis-Tsakonas. 1990. Deltex, a locus interacting with the neurogenic genes, Notch, Delta and mastermind in Drosophila melanogaster. Genetics 126:665-677. Xu, T., and G.M. Rubin. 1993. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117:1223-1237. Yacobi, A., J.P. Skelly, V.P. Shah, and L.Z. Benet, eds. 1993. Integration of Pharmacokinetics, Pharmacodynamics and Toxicokinetics in Rational Drug Development. New York: Plenum Press. 270 pp. Yamaguchi, T.P., K. Harpal, M. Henkemeyer, and J. Rossant. 1994. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev. 8(24):3032-3044. Yang, D.D., C.Y. Kuan, A.J. Whitemarsh, M. Rincon, T.S. Zheng, R.J. Davis, P. Rakic, and R.A. Flavell. 1997b. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene. Nature 389(6653):865-870. Yang, D., C. Tournier, M. Wysk, H.T. Lu, J. Xu, R.J. Davis, and R.A. Flavell. 1997a. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity. Proc. Natl. Acad. Sci. U.S.A. 94(7):3004-3009. Yates, J.R. III. 1998. Mass spectrometry and the age of the proteome. J. Mass Spectrom. 33:1-19. Zakeri, Z., D. Quaglino, and H.S. Ahuja. 1994. Apoptotic cell death in the mouse limb and its suppression in the hammertoe mutant. Dev. Biol. 165(1):294-297. Zeng, L., F. Fagotto, T. Zhang, W. Hsu, T.J. Vasicek, W.L. Perry, III, J.J. Lee, S.M. Tilghman, B.M. Gumbiner, and F. Costantini. 1997. The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90(1):181-192. Zhao, F., K. Mayura, R.W. Hutchinson, R.P. Lewis, R.C. Burghardt, and T.D. Phillips. 1995. Developmental toxicity and structure-activity relationships of chlorophenols using human embryonic palatal mesenchymal cells. Toxicol. Lett. 78(1):35-42. Zinaman, M.J., E.D. Clegg, C.C. Brown, J. O’Connor, and S.G. Selevan. 1996. Estimates of human fertility and pregnancy loss. Fertil. Steril. 65(3):503-509. Zuber, M.X., E.R. Simpson, and M.R. Waterman. 1986. Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells. Science 234(4781):1258-1261.

OCR for page 245
Scientific Frontiers in Developmental Toxicology and Risk Assessment This page intentionally left blank.